Gynecologic Cancer News

Healio spoke to Ashley Haggerty, MD, a board certified, fellowship-trained gynecologic oncologist at Hackensack Meridian Medical Group about recent advancements in endometrial cancer care.

CHICAGO — Most individuals with cancer who used an AI-based nutritional platform reported the application helped them regulate their diets and improved their quality of life, according to study results presented at ASCO Annual Meeting.

Compared with non-Hispanic white individuals, patients from racial and ethnic minority groups experienced similar clinical benefits when participating in phase 1 trials for advanced cancers, data published in JAMA Network Open showed.

When Ami P. Vaidya, MD, spent a week hiking to the top of Mount Kilimanjaro, everyone in her group hit a “low point” at various times in terms of energy and determination.

People with type 2 diabetes who use a GLP-1 receptor agonist have a lower risk for 10 types of obesity-associated cancer compared with those who use insulin, according to data published in JAMA Network Open.

Tisotumab vedotin for recurrent cervical cancer resulted in significantly longer survival outcomes compared with chemotherapy alone, according to results from a phase 3 randomized study published in The New England Journal of Medicine.

Transvaginal ultrasonography triage resulted in misclassification for more than one in 10 Black women, suggesting it is not a reliable strategy to identify Black women at risk for endometrial cancer, according to a diagnostic study.

CHICAGO — HPV vaccination rates for children and young adults increased substantially during the 2010s regardless of gender, race or ethnicity, according to findings presented at ASCO Annual Meeting.

Black women have higher rates of early death from tubo-ovarian, cervical and uterine cancers compared with women of other races and ethnicities, data show.

In this video, Ronny Drapkin, MD, discusses the importance of increasing ovarian cancer awareness in PCPs and OB/GYNs.